LEAH PATTON: Open Payments
NPI 1245955152 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 28 payments from 8 companies in 2025. Trend: 2023 $158 · 2024 $311 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $148 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Braeburn Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Medtronic, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INVEGA SUSTENNA, BRIXADI, COBENFY, SYMPLICITY G3, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
